Debra K. Liebert - 05 Jul 2022 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
MIST
Transactions as of
05 Jul 2022
Net transactions value
$0
Form type
4
Filing time
11 Aug 2022, 18:00:10 UTC
Previous filing
29 Jul 2021
Next filing
15 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Stock Option (right to buy) Award $0 +30,000 $0.000000 30,000 05 Jul 2022 Common Shares 30,000 $6.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest in twelve (12) equal monthly installments, beginning on August 5, 2022, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.